clinical trial · NCT06113237
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
Maternal ComplicationsPregnancy ComplicationBirth Outcomes, AdversePregnancyEpidiolex
brief summary
The purpose of this study is to evaluate pregnancy-related health outcomes in participants who are exposed to Epidiolex/Epidyolex during pregnancy and their infant up to 12 months of life.
started
Aug 5, 2025
primary completion
Aug 31, 2033
completion
Aug 31, 2033
last updated
Apr 13, 2026
official title
Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol